5 results for author:"Hoopmann M." in Literature citations
Results Customize
› Repeat search in UniProtKB (3)
| Acetylcholine receptor pathway mutations explain various fetal akinesia deformation sequence disorders. Michalk A., Stricker S., Becker J., Rupps R., Pantzar T., Miertus J., Botta G., Naretto V.G., Janetzki C., Yaqoob N. et al. Am. J. Hum. Genet. 82:464-476(2008) · UniProtKB (3) · Mapped (25) |
| The V109G polymorphism of the p27 gene CDKN1B indicates a worse outcome in node-negative breast cancer patients. Schondorf T., Eisele L., Gohring U.J., Valter M.M., Warm M., Mallmann P., Becker M., Fechteler R., Weisshaar M.P., Hoopmann M. Tumour Biol. 25:306-312(2004) · Mapped (8) |
| Expression of the tumor suppressor gene PTEN is not altered in the progression of ovarian carcinomas and does not correlate with p27Kip1 expression. Schondorf T., Hoopmann M., Eversheim B., Valter M.M., Becker M., Wappenschmidt B., Gohring U.J., Kubler T., Schmutzler R.K., Schafer R. Oncol. Rep. 10:1717-1722(2003) · Mapped (3) |
| HER-2/neu determination in blood plasma of patients with HER-2/neu overexpressing metastasized breast cancer: a longitudinal study. Hoopmann M., Neumann R., Tanasale T., Schondorf T. Anticancer Res. 23:1031-1034(2003) · Mapped (8) |
| Immunohistochemical analysis reveals a protective effect of H-ras expression mediated via apoptosis in node-negative breast cancer patients. Schondorf T., Rutzel S., Andrack A., Becker M., Hoopmann M., Breidenbach M., Gohring U.J. Int. J. Oncol. 20:273-277(2002) · Mapped (8) |